Humanwell Healthcare Group Co Ltd (600079 SHG) stock market data APIs
¥21.0195
0.18(0.9%)
as of October 31, 2025
Try our APIs with
free plan!
Humanwell Healthcare Group Co Ltd Financial Data Overview
Price chart is built with
Anychart
Humanwell Healthcare (Group) Co.,Ltd. researches, develops, produces, and sells pharmaceutical products in China and internationally. The company offers sufentanil citrate injection, an analgesic drug for combined anesthesia; remifentanil hydrochloride injection for induction of general anesthesia and maintenance of analgesia during general anesthesia; hydromorphone hydrochloride injection for patients who require opioid analgesia; nabuphine hydrochloride injection for use as an analgesic for anesthesia induction; alfentanil hydrochloride injection, a narcotic analgesic; remizaren besylate injection for sedation and anesthesia during non-endotracheal intubation surgery; and mifepristone preparations for pregnancy prevention or termination. It also provides zuka wood particles for colds and cough; compound muniziqi granules to treat skin and gynecological diseases; urokinase injection for thromboembolic diseases; and neomycin sulfate API for the prevention and treatment of intestinal diseases in animals. In addition, the company offers progesterone, estrogen, androgen, cortical hormone, and other API products; steroid hormone products; natural plant-based medicines; central nervous system drugs; animal medicine; narcotics; and Uyghur medicine. Further, it is involved in the production of feed additive, formula food, medical devices, and agricultural products; technical development, exchange, and transfer; leasing of medical devices; conference, exhibition, inspection, and testing; property management; pharmaceutical contract manufacturing; cleaning, washing, and disinfection; warehousing and logistics; and investment management and consulting services. The company exports its products to approximately 70 countries. The company was formerly known as Wuhan Humanwell Healthcare (Group) Co., Ltd. and changed its name to Humanwell Healthcare (Group) Co.,Ltd. in March 2013. Humanwell Healthcare (Group) Co.,Ltd. was founded in 1988 and is based in Wuhan, China.
Prev. Close
21.0195
Open
21.197
High
21.4746
Low
21.1785
52 wk Range
19.37-25.9
Market Cap
34 505 M
P/E Ratio
24.2989
Shares Outstanding
1 632 M
Revenue
24 175 M
EPS
0.26
Dividends (Yield)
0.0152
Beta
0.462
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Humanwell Healthcare Group Co Ltd (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Humanwell Healthcare Group Co Ltd data using free add-ons & libraries
Get Humanwell Healthcare Group Co Ltd Fundamental Data
Humanwell Healthcare Group Co Ltd Fundamental data includes:
- Net Revenue: 24 175 M
- EBITDA: 3 887 M
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2024-10-29
- EPS/Forecast: 0.3
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Humanwell Healthcare Group Co Ltd News
New
Jissbon Condom Maker Lifestyles China Weigh $300 Million HK IPO, Sources Say
(Bloomberg) -- The firm behind brands including Jissbon condoms is considering a Hong Kong initial public offering that could raise about $300 million, according to people familiar with the matter. M...
Owners of Condom Maker Lifestyles Mull $500 Million Sale
(Bloomberg) -- The owners of Lifestyles Healthcare are weighing a sale of the condom and lubricants maker’s operations outside of China for about $500 million, according to people familiar with the ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
